Login / Signup

Obesity paradox in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy.

Ji Hyun LeeTae-Seok SeoJin Seok AhnEliseo GuallarJuhee ChoHo Yun Lee
Published in: Journal of cachexia, sarcopenia and muscle (2023)
In Asian patients with advanced non-small cell lung cancer who received immune checkpoint inhibitors, obese BMI was associated with favourable overall survival independent of skeletal muscle or visceral fat mass.
Keyphrases